• Plant-Based Diet Pill that Helps with Weight Loss

    Plant-Based Diet Pill that Helps with Weight Loss

    Friday, May 28, 2021 was chosen to be the official release for a plant-based diet pill that helps with weight loss. The name is OxiTrim and the company that promotes the sale is the Applied Scientific Research Center in Colorado. Analysis of the claims of weight loss The two effective ingredients in OxiTrim are … [Read More...]

  • Anti-Viral Photodynamic Therapy (PDT) Can Treat Covid-19 Successfully

    Anti-Viral Photodynamic Therapy (PDT) Can Treat Covid-19 Successfully

    A German research team wanted to test whether an anti-viral photodynamic therapy (PDT) can treat Covid-19 successfully. They went to Tehran during the first Covid-19 peak in 2020 and did the following experiment. All patients of the clinical trial were in the early stage of Covid-19. The researchers compared 20 … [Read More...]

  • Research about Side Effects of the AstraZeneca Vaccine

    Research about Side Effects of the AstraZeneca Vaccine

    Research about side effects of the AstraZeneca vaccine revealed some worrisome facts. An article that appeared in the German “Frankfurter Allgemeine Zeitung” explained that people should not worry about the vaccine. The heading of the article was:” People no longer have to be afraid of the AstraZeneca-Vaccine.” … [Read More...]

  • The Power of a Placebo

    The Power of a Placebo

    A publication in Nature Communications investigated the power of a placebo. Specifically, they wanted to know whether there is a difference between a hidden and a known placebo. With a hidden placebo the patient is unaware whether a pill is a placebo pill or a real medication. With a non-deceptive or known placebo, … [Read More...]

  • Which are the Most and Least Contaminated Crops

    Which are the Most and Least Contaminated Crops

    View Post Farmers are spraying many crops with pesticides, so which are the most and least contaminated crops? Recently, the Environmental Working Group's 2021 Shopper's Guide to Pesticides in Produce was published. The various fruit and vegetables are also called the “dirty dozen”. You see from this readily that … [Read More...]

  • Pollen Allergies Make Covid-19 Infection Rates Worse

    Pollen Allergies Make Covid-19 Infection Rates Worse

    A recent study showed that pollen allergies make Covid-19 infection rates worse. This was published in the Proceedings of the National Academy of Sciences (PNAS) in March 2021. The study determined that airborne pollen exposure enhances susceptibility to respiratory viral infections. Specifically, this includes … [Read More...]

    Oct
    24
    2020

    Irregular Periods are Linked to Premature Deaths

    A review in CNN describes that irregular periods are linked to premature deaths. This review is based on the original publication in the British Medical Journal published on September 30, 2020.

    Essentially, the researchers followed 79,505 premenopausal women without a history of cardiovascular disease, cancer, or diabetes for 24 years. The researchers recorded 1975 premature deaths. The definition for a premature death was someone dying before the age of 70. There were three age groups that the researchers followed separately for 24 years.

    • ages 14-17 years
    • 18-22 years
    • 29-46 years

    The most common causes of death were 894 from cancer and deaths from 172 strokes and heart attacks.

    Death rates after 24 years for the three subclasses just mentioned

    The researchers noted that there were differences in survival for different age groups. But there were also differences in survival for irregular periods versus prolonged intervals between periods. Crude mortality rates for 1000 person years of follow-up for women with normal versus irregular periods were as follows.

    Normal periods                                  Irregular periods

    14-17 age :  1.05                                            14-17 age:    1.0

    18-22 age:  1.23                                            18-22 age:    1.37

    29-46 age:  1.0                                              29-46 age:    1.68

    Women with a cycle length of 40 days or more had a higher mortality rate. The researchers compared this to women with a normal cycle length (26-31 days). Here are the data in detail for two age groups at the outset of the study.

    Women with a cycle length of 40 days or more                 

    Age 18-22:    1.34

    Age 29-46:    1.40

    Heart attacks and strokes followed these death statistics closest.

    Discussion

    The researchers concluded that teenagers and women in their middle-age were at the highest risk. This risk was for premature mortality, if they had irregular periods or a cycle length of 40 days or more. There was also an association between irregular periods and a prolonged cycle length and type 2 diabetes, ovarian cancer and coronary heart disease. In addition, mental health problems were also related, the study said.

    Dr. Adam Balen, a professor of reproductive Medicine at Leeds Teaching Hospitals in the UK said: “Young women with irregular periods need a thorough assessment not only of their hormones and metabolism, but also of their lifestyle so that they can be advised about steps that they can take which might enhance their overall health”.

    Too much estradiol in women and men can cause cancer

    In this context it is interesting that other studies have shown that unopposed estradiol may be the culprit for both irregular periods and larger intervals between periods. When estrogen is elevated in females, irregular periods can result. Unopposed estradiol can cause breast, uterine and ovarian cancer.

    In males who also have a small amount of estrogen in their blood, it is important that a larger amount of testosterone balances the two hormones. Otherwise there is a risk of prostate cancer.

    In addition, cardiovascular disease has been described as a side effect of standard hormone replacement therapy (HRT) in women with synthetic hormones.

    The good news is that treatment with bioidentical hormones can treat these abnormal periods. This eliminates premature mortality and in many cases prolongs life.

    "<yoastmark

    Conclusion

    Researchers followed 79,505 premenopausal women without a history of cardiovascular disease, cancer, or diabetes for 24 years. They found that there is a linkage between irregular periods and premature deaths. There were three age groups that the researchers followed. Some of them suffered from irregular periods and others had periods that were 40 days or longer apart. The researchers recorded the premature mortalities. At an age of 29-46 there was a 68% higher mortality in women with irregular periods. The scientists compared this to women who had regular periods. In addition, women aged 29-46 with a cycle length of 40 days or more had a 40% higher mortality.

    Estrogen dominance could explain premature deaths

    The researchers compared this to women with a normal cycle length. It is possible that women who died prematurely were having too much estrogen in their system, which can produce cardiovascular disease and cancer of the breast, uterus and ovary. Further studies need to clarify the mechanism behind irregular periods and why a cycle length of 40 days or more causes mortality.

    Oct
    17
    2020

    What can Happen to Your Body Over Months of Isolation

    A recent article by CNN describes what can happen to your body over months of isolation at home. The article is rather negative showing all the possible things that can go wrong. I have been isolated as well since March 2020. I handle the isolation differently than described in the article. I will comment to each point what can be done differently to avoid the complications mentioned.

    Muscle loss

    The CNN article makes the point that inactivity can make you lose muscle bulk within only one week. A lack of exercise weakens your muscle strength. And muscle strength has been associated with longevity.

    My comment:

    I do a brisk walk of 5 to 7 kilometers daily. This maintains my muscle bulk. But I have a treadmill in the basement and a couple of weights that I can use, if it rains outside.

    There is a danger that heart and lungs get weaker

    You need to raise your heart rate and you also need to perfuse your lungs through exercise. Many people do not like exercise. They sit in front of the TV for hours or they surf the net on the computer. Even just reading a book does not give you enough exercise to get your heart rate up and increase your lung perfusion.

    My comment:

    A brisk walk with proper distancing gives you fresh air, exercises your muscles, your heart and your lungs. It maintains your cardiovascular fitness.

    Weight gain

    Being home all the time allows you to look into the fridge more often and eat snacks that are processed. People tend to eat more often than 3 times a day. The end result is that you gain weight. In the beginning of the epidemic people stocked up on non-perishable foods. Often they contain more sugar and carbohydrates. Consuming these foods leads to weight gain. Wearing masks, frequent hand washing, isolation practices and change of normal routines makes people get stressed. Stress leads to overeating and weight gain.

    My comment:

    In the last 6 months that I did home isolation my body mass index (BMI) stayed in the 21.0 to 22.0 range. I ate three meals a day. I avoided processed foods as they are overloaded with sugar, salt and refined carbs. Once a month I do a 5-day fasting mimicking diet according to Dr. Longo. This ensures that my BMI stays within the range I indicated. Otherwise I eat a Mediterranean diet, which is anti-inflammatory.

    Your posture could suffer

    When you are seated in front of the computer or the TV you tend to engage in poor postures. This can lead to strains of your back, neck, shoulders and hips. Staring at the computer screen or the TV can also give you eye strain.

    My comment:

    The key is movement, such as getting up and walking around; doing other activities like lawn mowing, weed eating or doing dishes. This interrupts any longer stretch of bad posture.

    Your sleep quality can suffer

    The more exposure to sunlight during the day you get, the more vitamin D you produce in the skin. Some people lack the necessary enzymes in the skin to convert cholesterol into vitamin D. But exposure to sunlight also helps to reinforce your diurnal hormone rhythm. This is also called circadian rhythm. Avoid blue lights (TV, computer, iPhones etc.) in the evening before bedtime as this can interfere with a deep sleep later. Also go to bed early enough (between 10 and 11 PM) to allow your circadian rhythm to take over.

    My comment:

    Some people (above the age of 60) benefit from 3 mg of melatonin at bedtime. After the age of 60 people no longer produce enough melatonin in the pineal gland. If I wake up in the middle of the night, I take another 3 mg of melatonin prior to 3AM. Caution: after 3 AM melatonin can give you a bit of a hangover in the morning.

    Your brain can slow down

    The brain needs nutrition and exercise. Exercise can eliminate certain amino acid by-products that otherwise turn into neurotoxins. With exercise you even prevent neurotoxins to enter the brain.

    My comment:

    I find that I must at least do a brisk walk of 4 kilometers a day. It prevents back pain, helps me sleep better and keeps my mind clear. But as mentioned earlier I prefer doing a brisk walk for 5 to 7 kilometers a day. In the past (prior to March 2020 when the Covid-19 pandemic started) I went to the gym every day. When it finally reopened, they had one Covid-19 case at the gym. I decided that it is too dangerous to go back to the gym until a safe Covid-19 vaccine is available in the summer of 2021. I feel the same way about flying. It is not worth the risk. I can just stay local and do my own program. The pleasure of traveling can wait until the summer of next year.

    What can Happen to Your Body Over Months of Isolation

    What can Happen to Your Body Over Months of Isolation

    Conclusion

    A recent CNN article described the dangers of passively staying in home isolation. I felt that this article was on the negative side. I found that by including a regular brisk walking program into my daily lifestyle the day got more structured. I felt I had more energy and I had no aches or pains. If I spent too much time watching TV or spending in front of the computer, I developed back aches and felt sluggish. I incorporated a 5-day fasting mimicking diet according to Dr. Longo once per month into my regular Mediterranean diet. This allowed me to keep my body mass index in the 21.0- 22.0 range. Doing what I described above I could continue to hold my weight, have energy and stay pain free for many more months. But when the Covid-19 vaccine arrives in spring/summer of 2021 I hope that things will return to normal.

    Oct
    10
    2020

    Medical Myths about Aging

    Medical myths about aging are easy to debunk. Many people believe that it is inevitable that they become disabled as they age, their lives become unbearable, without passion, boring and full of pain. Some aspects of your health may decline with age, none of the myths discussed below is inevitably happening in everyone. Studies showed that a positive outlook on aging and life in general will help you to live longer and stay healthier.  Here I discuss 7 common myths about aging.

    Myth 1: Everyone will experience physical deterioration

    It is common for people to experience reduced muscle strength, increased blood pressure, excessive fat accumulation and osteoporosis. A study with 148 older patients showed that an expectation of reduced fitness in older age actually resulted in less physical activity when older age arrived.

    But you can maintain good cardiovascular function and good muscle strength with a regular exercise program.  This study showed that men and women can reduce mortality by exercising regularly, even in older age.

    Myth 2: Older adults cannot exercise

    There are several reasons why older people stop exercising or are afraid to start exercising. People use the excuse of their arthritis getting worse from exercise. But studies showed the opposite: joint function improves and joint pains are getting better with exercise. Your muscles get stronger and you are less likely to fall. Your heart and lungs are improving their functions and your mentation improves. Exercise increases the HDL cholesterol, which reduces the risk for heart attacks and strokes.

    Myth 3: As we age, we need less sleep

    For many years there was the notion that older people need less sleep. What was not known then was that people above the age of 60 have no appreciable secretion of melatonin from the pineal gland. But when they replace their melatonin deficiency by taking a nighttime dose of 3 mg at bedtime, they will sleep better and longer. They may need a second dose of melatonin in the middle of the night. We need 7 to 8 hours of sleep at night for our diurnal hormone rhythm.

    This will also slow down our aging clock.

    Myth 4: Your brain slows as you age

    Dementia is common when you get older. 13.9% have it at age 71 and older. 37.4% have dementia over the age of 90. But the majority, namely 86.1% in the 71+ age group and 62.6% above the age of 90 do not have dementia. A Mayo Clinic study showed that when the person engaged in artistic activities in midlife or later in life the risk for mild cognitive impairment (MCI) development was reduced by 73%, involvement in crafts reduced it by 45% and engagement in social activities by 55%. In a surprise finding the use of a computer late in life was associated with a 53% reduction in MCI development. These are very significant observations.

    Physical activity reduces risk for dementia

    Apart from stimulating your brain, physical activities also significantly reduce the risk for dementia. A synopsis of 11 such studies showed that dementia is reduced by 30% when physical activity is started in midlife and the person is aging compared to non-exercisers.

    Myth 5: Osteoporosis occurs only in women

    There is a serious misunderstanding about osteoporosis. Several factors work together that can cause osteoporosis. Women in menopause are more likely to develop it due to the missing ovarian hormones estrogen and progesterone. These hormones work together and stimulate vitamin D induced calcium deposition into bone as well as decreasing bone resorption.

    Vitamin K2 also deposits calcium into the bone. In postmenopausal women who take bioidentical hormone replacement, vitamin D and K2 the bone density remains strong. Unfortunately, the opposite is true in postmenopausal women who take synthetic hormones. Synthetic hormones have side chains that do not fit the natural hormone receptors of a woman. This is why osteoporosis persist. And, yes, men get osteoporosis, but typically 10 years later. Typically, they get into andropause where testosterone production declines 10 years later.

    Myth 6: People stop sex as they age

    With age men can develop erectile dysfunction (ED) and women vaginal dryness, both of which can interfere with having sex. A large study showed that only 0.4% of men in the age group 18-29 had ED. In the age group of 60-69 there were 11.5% who suffered from ED. What this means though is that 88.5% of men age 60-69 did not suffer from ED. Fortunately for those who have ED drugs like Cialis and Viagra can correct their problem and they can have regular sex. What a change from 25 years ago when none of these drugs were available (approval of Viagra by FDA in 1998 and of Cialis in 2003).

    Bioidentical hormone replacement beyond menopause and andropause preserves your normal sex drive as well. There are additional benefits of bioidentical hormones. They have positive effects on the heart, brain, bones and the muscle mass.

    Myth 7: It is too late to stop smoking now

    One of the myths that many older smokers like to say is that it would be too late to stop smoking. They think the damage to heart and lungs is permanent and quitting now is too late. Fact is that quitting smoking immediately improves your blood circulation and gives you more oxygen. In just 1 year the risk of getting a heart attack is cut into half. In 10 years, the risk of a heart attack or stroke is the same as that of non-smokers. There is a reduction of getting lung cancer by half.

    Medical Myths About Aging

    Medical Myths about Aging

    Conclusion

    There are all kinds of medical myths about aging. We may think that physical deterioration is inevitable. Or we believe that older people cannot exercise. And we cannot help it, but our brain slows down as we get older. And there is the question whether we need less sleep as we age. Osteoporosis is a disease of women, is it not? These older couples, they don’t have sex any more, do they? And is it too late to stop smoking now that I am 65 years old? All of these myths exist, but there is a need to debunk them.

    The truth behind the medical myths about aging

    I explained in detail what the medical truths are behind these questions. Many of these myths have developed in the past. But with regular exercise, balanced nutrition (Mediterranean diet) and a positive attitude much of these old myths can be overcome. Bioidentical hormone replacement when hormones are missing is another powerful tool. Yes, we all age. But we are still living and can enjoy life as long as it lasts.

    Oct
    03
    2020

    Fibrotic Eye Disease Responds to Nicotinamide (Vitamin B3)

    A new study from Mt. Sinai Hospital showed that fibrotic eye disease responds to nicotinamide (vitamin B3). In general, during wound healing there can be aggressive cell transformations.  This can cause scarring, retinal detachment and finally loss of vision and even blindness. Notably, the following pieces of evidence support the notion that vitamin B3 (nicotinamide) helps to make eye diseases better.

    Lab experiments made in Petri dishes

    Specifically, researchers performed experiments in Petri dishes with human adult cells. After adding nicotinamide, they found the following.

    • There were no harmful cell transformations
    • Membrane formation in conjunction with scar formation was reversed
    • There is a slow-down regarding the development of eye diseases that lead to loss of vision and blindness

    Vitamin B3 was first detected as a cure to Pellagra

    Pellagra, the vitamin B3 deficiency was first described by the Spanish physician, Don Gaspar Casal in 1763. Typically, pellagra presents with dermatitis, diarrhea and dementia. If left untreated it will lead to death. The skin showed inflammation, particularly in areas where there was exposure to the sun or to friction. Affected skin may be darker. Pellagra occurs mainly in the developing world, particularly in sub-Saharan Africa.

    Experiments with vitamin B3 on mice curing eye disease

    In a mouse model researcher showed that vitamin B3 could largely prevent the development of glaucoma in aging mice. According to these researchers 93% of the mice with the higher dose of vitamin B3 did not develop glaucoma. Vitamin B3 (the precursor of nicotinamide) is important for the production of NAD+ and the phosphorylated form NADP, which are cofactors in the energy producing metabolism of mitochondria.  

    Experiments on rabbits showing a cure with nicotinamide

    In a 1985 publication rabbits were subjected to a vitamin B3 inhibitor, namely 6-aminonicotinamide. This is an antimetabolite of nicotinamide. It was given by intraabdominal injection. The rabbits developed diarrhea, ascending paresis/paralysis and death. They also developed vascular lesions in the eyes, particularly the iris with an acute inflammation of the iris, which physicians call iritis. The ocular lesions could be prevented by administering nicotinamide. The researchers concluded that vitamin B3 deficiency was responsible for the eye lesions.

    Clinical trials show a response of glaucoma to vitamin B3

    In a clinical trial physicians compared 34 primary open-angle glaucoma (POAG) patients with a control group of 30 age- and sex-matched controls. The researchers measured plasma nicotinamide concentration in both groups. The POAG patients had on average 33% lower nicotinamide plasma levels than the control group. They concluded that glaucoma seems to be associated with lower plasma nicotinamide levels. The research team suggested that these findings need to be confirmed in a larger series of glaucoma patients. They also suggested that vitamin B3 therapy could become one of the treatment modalities.

    Fibrotic Eye Disease Responds to Nicotinamide (Vitamin B3)

    Fibrotic Eye Disease Responds to Nicotinamide (Vitamin B3)

    Conclusion

    We know vitamin B3 deficiency mainly as pellagra. It occurs mainly in the developing world, particularly in sub-Saharan Africa. But newer experiments in vitro, in mice and in rabbits showed that vitamin B3 deficiency can also cause eye disease. Other studies showed that fibrotic eye disease responds to nicotinamide (vitamin B3). In addition, a clinical trial in humans showed that glaucoma can develop as a result of a 33% lack of plasma nicotinamide (vitamin B3) level. Regular supplementation in those who are prone to vitamin B3 deficiency may be curative for eye disease.

    Sep
    26
    2020

    A New Antibiotic Against Methicillin Resistant Staphylococcus aureus

    A US study describes a new antibiotic against methicillin resistant Staphylococcus aureus. It is a lysin-based antibacterial agent.

    Physicians have been looking for years for a solution regarding the increasing antibiotic resistance problem. But several attempts in the past have failed.

    Staphylococcus infections are the most common bacterial infections of human skin, of soft tissue, joints, bones, and pneumonia. In addition, it can cause endocarditis (=infection of heart valves) and lead to blood poisoning (septicemia).

    Staphylococcus aureus is the underlying bacterium behind staph infections. With the introduction of new antibiotics  it takes only 1 to 2 years before this bacterium learns to become resistant. Researchers noticed that the bacteria start to produce lysins and suddenly they are resistant to the latest antibiotic. Further research zeroed in on lysostaphin, which was active against resistant Staphylococcus bacterial strains.

    Deimmunized lysostaphin

    Lysostaphin is an antibacterial peptide described here in detail. But there still was some interference with immunologically active surface antigens that scientists were later able to overcome. Researchers succeeded lately in removing some of the surface antigens and develop deimmunized lysostaphin. This is what this publication is all about.

    It describes how T cells cannot detect the surface antigen properties of deimmunized lysostaphin. This way none of the strength of deimmunized lysostaphin gets lost in the fight against resistant staphylococcus that normally form anti-drug antibodies. Researchers pointed out the importance of the deimmunization process to make deimmunized lysostaphin invisible to the T cells of the immune system.

    Vigorous testing of deimmunized lysostaphin

    The researchers who investigated the efficiency and safety of deimmunized lysostaphin did the following tests.

    • Although lysostaphin was deimmunized, it retained potent in vitro and in vivo anti-staphylococcal activity. In vitro studies involving Petri dishes with methicillin resistant Staphylococcus aureus showed the effectiveness of deimmunized lysostaphin. In vivo testing in a mouse and rabbit model also showed effectiveness.
    • Deimmunized lysostaphin showed reduced immunogenicity in vivo. Researchers tested this in mice and compared the results to regular lysostaphin, where there was a swift immunological response.

    More points regarding deimmunized lysostaphin

    • Immune evasion allows for repeated efficient dosing of deimmunized lysostaphin. This means that the physician can administer the antibiotic (the deimmunized lysostaphin) to fight the methicillin resistant Staphylococcus aureus with several daily doses.
    • The deimmunization process allows deimmunized lysostaphin to evade the immune response that occurs to regular lysostaphin. This prevents future resistance development. It also prevents that the immune responses weaken the anti-methicillin resistant Staphylococcus aureus response.
    • Researchers showed in a difficult rabbit endocarditis model that deimmunized lysostaphin treats MRSA infection successfully. Endocarditis is an infectious disease, which is both difficult to treat in rabbits, but also in humans. For this reason, rabbits are often used as a model when new antibiotics are developed. If they are successful in the rabbit model they often get approval later for human treatments.

    Deimmunized lysostaphin in humans

    Unfortunately, we are still a few years away from using deimmunized lysostaphin in humans. After successful use of lysostaphin in mice and rabbits the next logical application is to launch human clinical trials. I am convinced that this will be the next step and very likely will be successful.

    A New Antibiotic Against Methicillin Resistant Staphylococcus aureus

    A New Antibiotic Against Methicillin Resistant Staphylococcus aureus

    Conclusion

    Researchers found a new antibiotic against methicillin resistant Staphylococcus aureus in a lysin-based antibacterial agent. This peptide has surface antigens that scientists had to removed to make it more effective. The end result was a deimmunized lysostaphin. Researchers tested this new antibiotic that is effective against many antibiotic resistant strains of bacteria successfully in mice and rabbits. The next step is testing in humans. This involves several phases of clinical trials. These clinical trials have to show that there is a lack of toxicity. In addition, they have to show that the new antibiotic is effective against resistant bacteria. I estimate that this process can still take about 5 years from now before the clinician can use this antibiotic routinely. As the new antibiotic is a polypeptide, it the patient cannot take it orally, as the gut is digesting it. The patient has to take it by injection.

    Sep
    19
    2020

    Hair Style Products are Mostly Safe

    A recent study concluded that hair style products are mostly safe when it comes to causing cancer. In the past there was some concern that the dyes for hair coloring could cause cancer. In a previous blog I mentioned that hair stylists are at a greater risk for developing bladder cancer.  But in customers who had their hair colored this was more difficult to prove. The new study reviewed by CNN was based on a large cohort of 117,200 female nurses at Brigham and Women’s Hospital in Boston.

    These 30-55-year-old nurses were observed for 36 years. Detailed information about hair coloring was part of the study.

    Results of the hair coloring study

    Women with light and medium use of hair dyes did not develop non-melanoma skin cancers, hematopoietic cancers or squamous skin cancers. The same was true for bladder cancer, melanoma, estrogen receptor positive breast cancer, progesterone receptor positive breast cancer and hormone receptor positive breast cancer. Furthermore hair coloring did not cause brain cancer, colorectal cancer, kidney cancer and lung cancer. 5% of women who ever used hair dyes did develop basal cell skin cancer; there was a total of 22,560 basal cell cancers that occurred.

    The BJM showed that women who colored their hair regularly (termed “cumulative dose”) developed 24%-31% more breast cancer. This breast cancer was estrogen negative breast cancer (31%) and progesterone negative breast cancer (24%). They also developed 24% more ovarian cancers and 17% colorectal cancer than controls who did not dye their hair. Myeloid leukemias were also more common in the heavy use hair coloring group with 29% and follicular lymphomas with 13%. Other forms of leukemia were not more frequent.

    Discussion

    50% to 80% of women and about 10% of men ages 40 and older are using hair dye regularly in the United States and Europe. The above cited cancer frequencies were based on women with dark hair and a cumulative dose of more than 200 applications of permanent hair dye. Translated into years of application of hair dye this means coloring your hair for 16 to 17 years, if you color your hair once a month. The study is very powerful due to the large number of women examined and the amazingly long time of 36 years of observation.

    Heavy use, medium and light use of hair dyes

    It is interesting to note that only the heavy use of hair dye resulted in a few significant cancer figures. The light use (1 to 99 times) and medium use (100 to 199 times) of hair dyes did hardly lead to any cancer. There were some exceptions where light use of hair dye led to 34% more bladder cancer and to 67% more follicular lymphomas. These were oddities, because the lighter use of hair dyes led to higher amounts of these cancers than medium and heavy use. This is not what the researchers expected.

    Hodgkin’s lymphoma and breast cancer

    Hodgkin’s lymphoma was about 3- to 5-fold more common in all hair coloring categories compared to non-use of hair dye. The authors discussed subgroups of women as well. They noticed that black women using permanent hair dye had a higher risk to develop breast cancer than white women who only had a borderline increased risk. Estrogen negative, progesterone negative and hormone negative breast cancer was more likely to be caused by heavy use of hair dyes.

    No association between the following cancers and hair dye use

    The present study could not find an association between ever using hair dye and the following. The study found no association with cutaneous squamous cell carcinoma, melanoma, ovarian cancer and colorectal cancer. In addition there also was no association with  kidney cancer, lung cancer, and brain cancer. But it found a slight increased risk (5%) of basal cell carcinoma.

    The study contains no information regarding the specific ingredients in hair dye that are carcinogenic. In the US supervision of permanent hair dyes by the FDA is rather loose. This leaves the manufacturer mostly in charge regarding the composition of the hair dyes. This is different in Europe and in Japan. Here manufacturers removed several carcinogenic substances from hair dyes because of regulations by the local regulatory bodies. This could have a cancer-lowering effect in these countries.

    Hair Style Products are Mostly Safe

    Hair Style Products are Mostly Safe

    Conclusion

    This large study from the British Medical Journal, published Sept. 2, 2020 explains the relationship of cancer risk to permanent hair dyes. The study lasted 36 years and involved 117,200 female nurses. More than 96% of the women were Caucasians. This study showed that for most people who use permanent use hair dyes there is no association with most cancers. However, there was an association between a few cancers and the use of hair dyes. These were in 5% basal cell skin cancers. But breast cancer (31% estrogen receptor negative, 24% progesterone receptor negative), ovarian cancer (24%) and 17% colorectal cancer were among these too. There was also an increased risk of Hodgkin’s lymphoma.

    Effect of screening by FDA regarding carcinogenic substances in hair dyes

    All this data was based on the hair dyes used in the US. Supervision of permanent hair dyes by the FDA is rather loose, with the manufacturer being mostly in charge. This is different in Europe and in Japan. Here local regulatory bodies instructed manufacturers to remove several carcinogenic substances from hair dyes. This could have a cancer-lowering effect in these countries.

    Sep
    12
    2020

    Tesamorelin Reduces Fat Content of Non-Alcoholic Fatty Liver Disease

    A new study showed that tesamorelin reduces fat content of non-alcoholic fatty liver disease. This substance and its effects are explained later in this article. Notably, the publication came out in the journal JCI insight on July 23, 2020.

    For one thing, with the world-wide obesity problem fat deposits in the liver became more frequent. To clarify, the medical profession calls this non-alcoholic fatty liver disease (NAFLD). 20-30% of all adults in the US suffer from this liver condition. By all means, currently there is no treatment for this condition. Chronic inflammation often leads to liver fibrosis. This in turn can progress to liver cirrhosis, which potentially is fatal. A small percentage can even develop hepatocellular carcinoma, which often ends the patient’s life because of multiple metastases.

    Reduction of liver fat in HIV patients

    The endocrinologist Steven Grinspoon, MD, is the chief of the MGH Metabolism Unit. MGH stands for Massachusetts General Hospital. Dr. Grinspoon published a study on HIV patients that showed that tesamorelin can reduce liver fat of HIV patients.  In the same study he also showed that tesamorelin could halt progression of fibrosis in the liver. Tesamorelin (brand name: Egrifta) is a human growth hormone releasing factor. It has been approved by the FDA for fat accumulation in the livers of HIV patients. HIV patients take several medications to cure their HIV. One of the side effects is a lipodystrophy, as doctors call this fat accumulation in their liver. Dr. Grinspoon published the results of a clinical trial with HIV patients that showed that tesamorelin successfully treated the fatty liver condition in HIV patients.

    Mechanism of tesamorelin

    The mechanism of tesamorelin on the liver metabolism is depicted in this image. You can see that tesamorelin, a growth hormone releasing hormone (GHRH) analogue, augments pulses of growth hormone (GH) secretion of the anterior pituitary gland. We know from other literature that growth hormone melts away fatty tissue, builds up muscle strength and provides extra energy. Specifically, when it comes to liver tissue, GH reduces inflammation and increases oxidative phosphorylation in the mitochondria. The mitochondria are the energy producing sub particles in every body cell. This is where oxidative phosphorylation takes place, a biochemical reaction that produces energy. Normally hepatocellular carcinoma has a poor prognosis. But in the presence of patients with hepatocellular carcinoma who receive tesamorelin have an improved outlook. IGF-1, a hormone produced by the liver in response to HG increases as well, which strengthens muscles and gives you energy. 

    Non-alcoholic fatty liver disease (NAFLD) in HIV patients and patients without HIV

    I indicated before that in HIV patients with non-alcoholic fatty liver disease (NAFLD) the substance tesamorelin can reduce the extra fatty tissue in the liver. The original investigation took place over 1 year. Dr. Grinspoon is currently investigating the effects of tesamorelin in obese patients who do not have HIV. Preliminary clinical data are encouraging, but Dr. Grinspoon is conducting more investigations.

    Effect of tesamorelin on several gene sets

    The researchers did liver biopsies in both the treatment arm with tesamorelin and the placebo group over 1 year. These samples underwent a gene analysis. Researchers found that tesamorelin influenced 14 genes significantly. For example, oxidative phosphorylation was upregulated in tesamorelin treated patients, but downregulated in placebo patients. Inflammation was influenced by 5 gene sets that were downregulated in the tesamorelin patient group, but upregulated in the placebo group. Tesamorelin also stimulated several genes affecting the immune system. The authors discuss that they found decreased phosphorylation in the mitochondria of patients with NAFLD. On the other hand, when they administered tesamorelin oxidative phosphorylation recovered in the mitochondria.

    Progression of NAFLD to cirrhosis of the liver and hepatocellular carcinoma

    The researchers suggest that mitochondrial impairment may play a key role regarding fat accumulation in the liver. When the mitochondria do not work optimally, toxic lipid metabolites can accumulate in the liver that destroy liver cells, lead to inflammation, increase oxidative stress and cause fibrosis. These are the key elements that allow NAFLD to progress to cirrhosis of the liver and hepatocellular carcinoma.

    Side effects of tesamorelin

    The patient administers tesamorelin (Egrifta) by injection once a day at bedtime. The dosage is 0.2 to 0.3 micrograms subcutaneously. There can be redness or itching at the injections site, depression and muscle aches or spasms. Sleep problems and night sweats are also possible. In addition, there may be nausea, vomiting or stomach pains. Overall patients tolerate the medicine is relatively well. But it is expensive. A one-month treatment costs about 1000 $. Not everybody can afford that.

    Tesamorelin is an epigenetic gene therapy

    Tesamorelin therapy is a new type of treatment modality. It increases growth hormone production in the pituitary gland. As explained above there is upregulation or downregulation of about 14 various genes leading to a slow disappearance of NAFLD fat in the liver. This was originally described in HIV patients, but subsequently  also found in non-HIV patients as well. As the genes have not been altered, but the expression of the genes has changed, this is considered an epigenetic therapy similar to good lifestyle factors. It is not gene therapy, because the genes have not been permanently changed.

    Tesamorelin Reduces Fat Content of Non-Alcoholic Fatty Liver Disease

    Tesamorelin Reduces Fat Content of Non-Alcoholic Fatty Liver Disease

    Conclusion 

    Tesamorelin reduces fat content of non-alcoholic fatty liver disease.Tesamorelin is a growth hormone releasing hormone analogue that augments pulses of growth hormone (GH) secretion of the anterior pituitary gland. We know from other literature that growth hormone melts away fatty tissue, builds up muscle strength and provides extra energy. There are 14 genes that tesamorelin effects, some by upregulation, some are downregulation. But this new epigenetic therapy is what can remove excessive fat accumulation in the liver as is seen in NAFLD. This is an example of causative treatment versus symptomatic treatment, what conventional medicine normally engages in. Time will tell whether other side effects will come up that researchers have not yet noted.

    Sep
    05
    2020

    How to Manage Clot Formation with Covid-19

    A publication in the Canadian Medical Association Journal describes how to manage clot formation with Covid-19. A significant amount of cases among Covid-19 patients come down with clotting problems. This means that an infection with SARS-CoV-2 (or Covid-19 coronavirus) may initially present with a fever and cough. But a few days later it can suddenly turn into a dangerous disease with severe clots, multiple organ failures and death.

    Clot occurrence with Covid-19

    It is important to realize that most patients with SARS-CoV-2 do not need hospitalization. But physicians admit 10 to 15% of patients to the hospital. Of these 20% end up with treatment in the Intensive Care Unit (ICU). Of all the hospitalized patients between 5% and 30% develop some form of thrombotic event. Notably, complications of clot formation can be a stroke, a heart attack, a pulmonary embolism or a deep vein thrombosis in the leg. In a recent study from the US 400 random hospitalized patients with Covid-19 144 patients were admitted to the ICU. 4.8% had radiologically confirmed deep vein thrombosis. Overall there were 9.5% with thrombotic events that developed during the hospital stay.

    How does a coagulopathy develop with Covid-19?

    Truly, SARS-CoV-2 enters the body cells through an interaction of its viral spike protein with the angiotensin-converting enzyme 2 (ACE2) receptor. To explain, numerous organs and tissues express this receptor. This includes lung alveolar type 2 epithelial cells, endothelium, the brain, heart and kidneys. To emphasize, ACE2 leads to angiotensin II degradation. With the SARS-CoV-2 stimulation of the ACE2 receptor there may be an accumulation of angiotensin II, which causes a procoagulant state. Injury of the endothelium explains inflammation in the lining of the blood vessels in multiple organs. Commonly affected organs are lungs, heart, kidneys and intestines. The inflammatory reaction is what can lead to clot formation. When part of an organ has died off because of mini clots that destroyed part of the organ, this process can eventually lead to organ failure. Lung failure, heart failure and kidney failure can develop in these sick patients.

    Adequate vitamin D blood levels are important for the immune system

    By all means, vitamin D is very important for the integrity of the immune system. With vitamin D blood levels below 15 to 20 ng/mL (37.5–50 nmol/L) the immune system is paralyzed, and any viral or bacterial infection tends to overwhelm the body. Of course, this is the reason why the mortality due to Covid-19 coronavirus is highest in patients with these low vitamin D blood levels. People with secondary illnesses (diabetes, arthritis, autoimmune diseases, cancer) and patients above the age of 60 have the lowest vitamin D blood levels and have the highest mortality rates. This publication describes this in more detail.

    Best vitamin D blood level is in the upper normal range (50-80 ng/mL)

    Above a vitamin D blood level of 30 ng/mL (=75 nmol/L) a patient’s immune system is functioning normally. However, the immune system is strongest at a vitamin D blood level of 50–80 ng/mL (125–200 nmol/L), which is the upper range of the normal level for vitamin D in the blood.

    Keep in mind that vitamin D toxicity occurs only above 150 ng/mL (375 nmol/L).

    Specific effects of vitamin D on Covid-19

    There are three major effects that vitamin D has.

    1. A strengthening of the epithelial barrier not allowing the coronavirus to penetrate into the lung tissue as easily.
    2. Release of defensins and cathelicidin, two crucial antiviral polypeptides that eradicate any virus in the system.
    3. Interruption of the “cytokine storm”, an overwhelming inflammation which is responsible for viral pneumonia to develop. Without the cytokine storm there is no damage to the lungs and people do not need treatment in the ICU. This is particularly important for people above the age of 60 and for people with pre-existing diseases.

    In like manner, with the stabilizing effect of vitamin D regarding the immune function more severe forms of Covid-19 can turn into less severe forms with a better outcome.

    Treatment of patients with Covid-19 who have clotting problems

    Patients need to be assessed with respect to their risk of developing clots. This publication describes that high risk patients have elevated D-dimer levels. When blood clots dissolve the body produces D-dimer, a protein fragment. Normally the D-dimer test is negative in a person that does not produce clots. But in sick patients with Covid-19 who form clots this blood test typically shows D-dimer >2500 ng/mL. In addition the tests show high platelet counts (more than 450 × 109/L), C-reactive protein (CRP) >100 mg/L and an erythrocyte sedimentation rate (ESR) >40 mm/h.

    Indeed, with this constellation of blood tests in a severe Covid-19 case in the ICU setting, the physician uses heparin intravenously or subcutaneously to counter clot formation. However, this needs to be balanced against the risk of causing severe internal bleeding.

    Separate from the anticoagulant effect, heparin seems to also suppress inflammatory cytokine levels. In addition, heparin suppresses neutrophil chemotaxis and migration. Physicians rescued many patients from death using heparin therapy.

    Risk versus benefit clinical trials of heparin therapy are required

    At this point there are only retrospective clinical trials available to describe risk versus benefit of heparin therapy. Some show no difference, others do. There are two international clinical trials on their way to shed more light on this situation. Until the results of these clinical trials are available, physicians need to treat patients to the best of their knowledge.

    How to Manage Clot Formation with Covid-19

    How to Manage Clot Formation with Covid-19

    Conclusion

    Clot formation in sick Covid-19 patients is responsible for many deaths in Covid-19 patients. The SARS-CoV-2 (or Covid-19 coronavirus) causes a cytokine storm with injury to the lining of the arteries. This can affect multiple vital organs and the condition may lead to organ failure. This activates the clotting system and causes clots all over the body. When this process occurs, patients get very sick and the death rate climbs. Physicians were able to rescue some patients with heparin therapy. Two international clinical trials are on the way. Hopefully  these trials answer questions about this newer treatment method. The downside of heparin therapy is the complication of massive bleeding, which causes deaths as well. When it comes to Covid-19, don’t rely on curative medicine. Strengthen your immune system by preventative therapy like vitamin D3 that can interrupt the cytokine storm.

    And even with a “well-prepared” immune system it is extremely important to follow all the guidelines of distancing, disinfecting and wearing face masks. We need all the help we can get!

    Part of this was previously published here.

     

    Aug
    29
    2020

    Health Benefits from Vitamin C Supplements

    Notably, there are health benefits from vitamin C supplements as I will explain below. A recent publication in the Journal of Intensive Care stated that vitamin C may lower ventilator time for sick patients in the ICU. In this case, researchers performed  a meta-regression analysis. It is important to realize that higher doses of vitamin C changed the need for ventilation. Vitamin C given intravenously or by mouth significantly reduced the need for ventilation in sick patients. To explain, the researchers pooled eight clinical trials and compared them to a control group who did not receive vitamin C treatment. In detail, the researchers noted that there was a 14% reduction with regard to ventilator use in the treatment group. To clarify, they had received vitamin C infusions while patients who did not receive vitamin C infusions served as controls.

    Five of the clinical trials involved patients who received 10 hours or more ventilation treatment. Certainly, these patients were sicker than the average ICU patients. They experienced a 25% reduction of ventilator time after receiving between 1 and 6 grams of vitamin C. The physicians gave this intravenous or orally.

    History of Mega doses of vitamin C

    Indeed, in the 1940’s mega doses of vitamin C were given intravenously in an attempt to treat polio. Eventually, in the late 1960’s Linus Pauling called high doses of vitamin C the “healing factors for diseases”. But subsequent clinical investigations showed that vitamin C had limitations. The Oregon State University website reports that some of the claims about vitamin C in the past went overboard. Here are some points about vitamin C that we need to remember.

    • Vitamin C is an important cofactor in many enzymatic reactions, such as the biosynthesis of collagen, carnitine and neuropeptides. In addition, the regulation of gene expression requires vitamin C and vitamin C is an important antioxidant.
    • A prospective cohort study showed that higher vitamin C blood levels lowered the risk of high blood pressure, coronary heart disease and strokes.

    More effects of vitamin C

    • Patients in need of a surgical procedure benefitted from vitamin C. Researchers showed that vitamin C was a valuable adjunct to conventional medicine in cardiovascular disease  Vitamin C reduced arrhythmia and myocardial injury following cardiac procedures.
    • There is insufficient evidence that regular vitamin C intake prevents cancer. Randomized controlled clinical trials reported no effect of vitamin C on cancer.
    • 10 grams per day of vitamin C has no association with toxic or adverse effects in most people. However, some adults are more sensitive to vitamin C and develop gastrointestinal disturbances and diarrhea with megadoses of vitamin C. For these people physicians recommend  taking up to 2 grams per day of vitamin C.

    Vitamin C and disease prevention

    Several clinical trials involving vitamin C supplements showed significant positive effects on patients. Below I am briefly reviewing these clinical trials.

    Endothelial function

    Endothelial function was improved with doses of above 500 mg of vitamin C. This likely is the reason that there is a reduction of cardiovascular disease in people who consume 1000 mg of vitamin C daily.

    High blood pressure

    Vitamin C at 500 mg daily lowers high blood pressure. A clinical trial found that 500 mg of vitamin C daily lowers the systolic blood pressure by 3.84 mm mercury and the diastolic blood pressure by 1.48 mm mercury. Over several years’ time this can prevent premature heart attacks and strokes.

    Vitamin C and the immune system

    Vitamin C is a powerful antioxidant. It can neutralize reactive oxygen species, which are produced when the immune cells fight viruses and bacteria. Neutrophils, lymphocytes and phagocytes are all supported by vitamin C. Vitamin C and E co-operate in their antioxidant functions. Vitamin C is essential for a strong antibody response with bacterial or viral infections. I take 1000 mg of vitamin C once daily.

    Heart failure, strokes and heart attacks

    Many studies showed some effects on reduction of heart attacks, strokes and congestive heart failure. With respect to strokes there was a 42% risk reduction over 9.5 years when the highest vitamin C plasma level was compared to the lowest level. But results regarding heart attack prevention and prevention of CHF were only marginal.

    Cancer and vitamin C

    Stomach cancer: there was a 45% reduction of stomach cancer when high vitamin C plasma level cases were compared to low plasma level cases.

    Colon cancer: A pooled study based on 13 prospective cohort studies showed that vitamin C supplementation reduced colon cancer risk by 19%.

    Large B cell lymphoma: After 11 years of follow-up the Women’s Health Initiative found that vitamin C supplementation reduced diffuse large B cell lymphoma by 31%.

    Researchers could not show significant effects of vitamin C on other cancers.

    Type 2 Diabetes (=adult onset diabetes)

    A large European study going on for 12 years showed a strong inverse relationship between blood levels of vitamin C and the onset of diabetes. Patients with the highest vitamin C blood levels had a 62% lower risk of developing diabetes. Physicians compared this to low level vitamin C controls.

    Mortality reduction with vitamin C supplementation

    In the EPIC-Norfolk prospective study a clear inverse relationship was found with higher vitamin C blood levels and a reduction in risk of all-cause mortality.

    Recommended dietary allowance for vitamin C

    The official dietary recommendation for vitamin C in adults is 90 mg daily for males and 75 mg daily for females. However, in view of the above mentioned clinical trials I would recommend the following. Supplement with 500 mg to 1000 mg of vitamin C daily to have enough vitamin C reserves. The reason I say this is that the official dietary recommendation was based on preventing scurvy, the historic insufficiency disease of vitamin C. In addition, as mentioned before, vitamin C is safe to take up to 10 grams per day. Many physicians recommend taking a smaller amount of vitamin C found to prevent strokes, high blood pressure, type 2 diabetes, improve endothelial function and strengthen the immune system.

    Health Benefits from Vitamin C Supplements

    Health Benefits from Vitamin C Supplements

    Conclusion

    In my review I discussed health benefits from vitamin C supplements. Briefly, doctors noted that severely sick patients on respirators in the ICU setting were able to reduce the ventilator use.  This was significant after they received between 1 and 6 grams of intravenous or oral vitamin C. However, patients with the highest vitamin C supplementation had a 62% lower risk of developing diabetes than low level vitamin C controls. Vitamin C lowered high blood pressure moderately and prevented strokes by 42%. Vitamin C stimulates the immune system together with vitamin D, A, E and some trace minerals. There are many more health benefits from vitamin C supplements. The official dietary recommendation for vitamin C in adults is 90 mg daily for males and 75 mg daily for females. However, I take 1000 mg of vitamin C daily as the evidence shows that this is healthier.

    Aug
    22
    2020

    New Alzheimer’s Blood Test Is Promising

    A new Alzheimer’s blood test is promising according to a publication in the Journal of the American Medical Association (JAMA) July 29, 2020. Alzheimer’s disease is a devastating neurological illness where people lose memory and judgment. If affects about 5.8 million Americans above the age of 65. Specialists are estimating that there will be 14 million Alzheimer’s cases by the year 2050.

    For many years pathologists found amyloid plaque and tau tangles in Alzheimer’s patients’ brains, which accounted for their memory loss. Researchers developed a simple, inexpensive blood test, called phospho-tau217 (p-tau217). This is one of the tau proteins that is present in both plaques and tangles of living Alzheimer’s patients.

    Plaques and tangles in the brain of Alzheimer’s disease patients

    Many research papers describe that senile plaques are part of the cortex of brains of Alzheimer’s patients. They consist of beta-amyloid substance and of neurofibrillary tangles.

    To put it simple: This protein material is like glue, which prevents the neurons from working properly. It also causes the memory loss and the confusion so typical for Alzheimer’s patients. Over the years the question then arose, where this glue substance ”beta-amyloid” came from. Dr. Yasojima et al. pointed out that for many years it was thought that this abnormal protein would have come from the liver and was then deposited in the brain. However, this research group presented evidence that the beta-amyloid actually comes directly from the cells in the brain where it is found and also deposited.

    Beta-amyloid has antioxidant function

    The amyloid-beta precursor protein is important for normal membrane function in the brain. It also has a very important antioxidant function in normal brains and keeps lipoproteins, an important chemical substrate of the brain, from getting oxidized. Recent research from the University of Pittsburgh School of Medicine linked these plaques with a loss of nitric oxide production in the brain, which would lead to a reduction of perfusion of brain blood vessels. This in turn can lead to a loss of oxygen and nutrients in the brain tissue.

    Alzheimer’s patients have a regulation problem of amyloid-peptides

    The Alzheimer’s patient’s brain appears to have a regulation problem where through some genetic or other mechanism, the auto-regulation of amyloid-peptides and other similar peptides appears to have been lost. There seems to be an overproduction of these peptides until they are no longer soluble. The insoluble surplus of these beta-amyloids is then deposited as the glue-like senile plaques that clog up the patient’s thinking, and reactive oxygen species are also released in these plaques damaging nerve tissue.

    Back to why the new Alzheimer’s blood test is promising

    Oskar Hansson, MD, PhD, Professor of Clinical Memory Research at Lund University, Sweden, stated the following. “While more work is needed to optimize the assay and test it in other people before it becomes available in the clinic, the blood test might become especially useful to improve the recognition, diagnosis, and care of people in the primary care setting.” The p-tau217 blood test mentioned at the beginning of this review correlates with the clinical condition of Alzheimer’s patients. Researchers evaluated the test in 1302 patients. Some had cognitive impairment others did not. The participants came from 3 large studies in Arizona, Sweden and Columbia. The Arizona branch provided 81 participants, Sweden provided 699 and Columbia 522.

    Accuracy of the p-tau217 blood test

    In the Arizona branch researchers could distinguish between with or without a “high likelihood of Alzheimer’s with an accuracy of 98%.

    The Swedish BioFINDER Study discriminated between Alzheimer’s disease and other neurodegenerative diseases with an accuracy of 96%.

    Finally, in the Columbia branch of the study researchers distinguished between mutation-carriers and non-carriers. They could predict who would develop Alzheimer’s  20 years before patients developed cognitive deficits.

    All of the facts are not out yet about Alzheimer’s, but it is exciting to see the recent progress both in terms of early diagnosis and Alzheimer’s treatment. On the long-term prevention, as always in medicine, will prevail as the most effective method regarding diminishing the frequency of this disease.

    10 steps that everybody can do today to minimize the risk of developing Alzheimer’s disease

    1. take 2000 IU of Vit. D3 per day
    2. get a T3 and T4 blood test to rule out hypothyroidism (doctors often do not order T3)
    3. Measure lead and mercury levels in urine and stool, particularly if you have more than 3 amalgamate tooth fillings
    4. If you test positive for mercury, go for intravenous chelation therapy, which specifically removes heavy metals (including mercury) from your system.
    5. People who do regular exercises and follow good nutrition get less Alzheimer’s disease. As Alzheimer’s patients are deficient in magnesium intake, it is wise to take a magnesium supplement as discussed in Ref. 22.

    Further steps to prevent Alzheimer’s disease

    1. Omega-3-fatty acids (molecularly distilled Omega-3 or cod liver oil capsules etc.) and/or fish help you to preserve brain cells.
    2. Take the nutrient phosphatylserine (PS) 100 mg once daily for prevention of Alzheimer’s and dementia.
    3. Cutting out sugar and starchy food by following a low-glycemic diet brings elevated insulin levels back to normal.
    4. Mayo Clinic research recently showed that computer-based memory exercises in seniors will lead to significantly less Alzheimer’s disease in the years down the road.
    5. Progesterone cream (only bio-identical, from compounding pharmacy) has anti-Alzheimer effects. Women would incorporate this into their bio-identical hormone replacement schedule following menopause. Men would utilize the brain rejuvenating effect of testosterone into their hormone replacement routine following andropause.

    Both also take small amounts of oral DHEA and pregnenolone, but have blood or saliva tests from time to time to measure hormone levels.

    New Alzheimer’s Blood Test Is Promising

    New Alzheimer’s Blood Test Is Promising

    Conclusion

    Alzheimer’s disease is a severe, disabling neurodegenerative disease of the brain. At this point there has not been an early diagnostic test. But a recent publication in the Journal of the American Medical Association (JAMA) describes a simple blood test, called phospho-tau217 (p-tau217). This is one of the tau proteins that is present in both plaques and tangles of living Alzheimer’s patients. A clinical trial showed that when this test is positive, it predicts up to 20 years from now that this patient likely will come down with Alzheimer’s disease. Based on this publication there will soon be a simple blood test that diagnoses Alzheimer’s disease early and reliably with an accuracy of between 96% to 98%. Lifestyle interventions may then be able to prevent the deterioration of cognitive functions. Further therapeutic interventions may come about through more research.

    Part of the text was published before under the link indicated.